Risk assessment on change of testing requirements for partner donation of reproductive cells
In May 2011, the European Commission asked ECDC to estimate the change in total exposure risk to hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) during reproductive cell handling and storage for secondary parties, if the current scheme of testing at each cell donation would change to testing partner donors of reproductive cells once or twice a year.
ECDC Director Marc Sprenger: “Hepatitis B and C are a serious health problem in the EU, tailor-made screening is important”Archived
ECDC Director Marc Sprenger at the European Parliament Committee on the Environment, Public Health and Food Safety (ENVI) stressed the importance of the EU’s continuous commitment in the fight against hepatitis B and hepatitis C.
EMCDDA and ECDC join forces to address the challenge of hepatitis
Hepatitis and other drug-related infectious diseases will be the focus of ‘Hepatitis week’, taking place at the EU drugs agency (EMCDDA) in Lisbon from 12–16 June 2017. The initiative will bring together some 100 specialists from: EU Member States, candidate and potential candidate countries to the EU, as well as partner agencies, civil society and professional organisations.
Health risks during the Carnival season in Brazil
The Carnival season will last from 1 to 9 March 2019. In Rio de Janeiro, Brazil, 1 million participants are expected, including many travellers from Europe
Communicable Disease Threats Report, 19-25 May 2019, Week 21
The ECDC Communicable Disease Threats Report (CDTR) is a weekly bulletin for epidemiologists and health professionals on active public health threats. This issue covers the period from 19-25 May 2019 and includes updates on rat hepatitis B, dengue, Ebola virus disease, influenza, Legionnaires' disease and P. vivax malaria.
Rapid risk assessment: Public health risks related to communicable diseases during the hajj 2019, Saudi Arabia, 9–14 August 2019
In 2019, the hajj will take place between 9 and 14 August. The risk for EU/EEA citizens to become infected with communicable diseases during the 2019 hajj is considered low, thanks to the vaccination requirements for travelling to Makkah (Mecca) and the Saudi Arabian preparedness plans that address the management of health hazards during and after hajj.
- Food- and waterborne diseases
- Hepatitis A
- Hepatitis B
- Mass gathering
- Meningococcal disease
- Middle East respiratory syndrome coronavirus
- Public health threat
- Saudi Arabia
- Travellers' health
- Vaccine preventable diseases
- Vector-borne disease
The effectiveness and cost-effectiveness of screening for and vaccination against hepatitis B virus among migrants in the EU/EEA: A systematic review
Myran, D.T., Morton, R., Biggs, B.-A., Veldhuijzen, I., Castelli, F., Tran, A., Staub, L.P., Agbata, E., Rahman, P., Pareek, M., Noori, T., Pottie, K.